Skip to main content
Erschienen in: Journal of Cancer Education 2/2012

01.06.2012

Educating Health Care Professionals to Provide Institutional Changes in Cancer Survivorship Care

verfasst von: Marcia Grant, Denice Economou, Betty Ferrell, Gwen Uman

Erschienen in: Journal of Cancer Education | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

The Institute of Medicine (IOM) 2006 report, From Cancer Patient to Cancer Survivor: Lost in Transition (In M. Hewitt, S. Greenfield and E. Stovall (Eds.), (pp. 9–186). Washington DC: The National Academies Press, 2006) identifies the key components of care that contribute to quality of life for the cancer survivor. As cancer survivorship care becomes an important part of quality cancer care oncology professionals need education to prepare themselves to provide this care. Survivorship care requires a varied approach depending on the survivor population, treatment regimens and care settings. The goal of this program was to encourage institutional changes that would integrate survivorship care into participating centers. An NCI-funded educational program: Survivorship Education for Quality Cancer Care provided multidiscipline two-person teams an opportunity to gain this important knowledge using a goal-directed, team approach. Educational programs were funded for yearly courses from 2006 to 2009. Survivorship care curriculum was developed using the Quality of Life Model as the core around the IOM recommendations. Baseline data was collected for all participants. Teams were followed-up at 6, 12 and 18 months postcourse for goal achievement and institutional evaluations. Comparison data from baseline to 18 months provided information on the 204 multidiscipline teams that participated over 4 years. Teams attended including administrators, social workers, nurse practitioners, registered nurses, physicians and others. Participating centers included primarily community cancer centers and academic centers followed by pediatric centers, ambulatory/physician offices and free standing cancer centers. Statistically significant changes at p = <0.05 levels were seen by 12 months postcourse related to the effectiveness, receptiveness and comfort of survivorship care in participant settings. Institutional assessments found improvement in seven domains of care that related to institutional change. This course provided education to participants that led to significant changes in survivorship care in their settings.
Literatur
4.
Zurück zum Zitat American Society of Clinical Oncology (2011) Future supply and demand of oncologists: challenges to assuring access to oncology services Retrieved November 7, 2011, from www.asco.org/workforce American Society of Clinical Oncology (2011) Future supply and demand of oncologists: challenges to assuring access to oncology services Retrieved November 7, 2011, from www.​asco.​org/​workforce
5.
Zurück zum Zitat Aziz NM (2007) Late effects of cancer treatment. In: Ganz PA (ed) Cancer survivorship today and tomorrow. Springer, New York, pp 54–76CrossRef Aziz NM (2007) Late effects of cancer treatment. In: Ganz PA (ed) Cancer survivorship today and tomorrow. Springer, New York, pp 54–76CrossRef
6.
Zurück zum Zitat Burkett V, Cleeland CS (2007) Symptom burden in cancer survivorship. [PDF]. Journal of Cancer Survivorship 1(2):167–175PubMedCrossRef Burkett V, Cleeland CS (2007) Symptom burden in cancer survivorship. [PDF]. Journal of Cancer Survivorship 1(2):167–175PubMedCrossRef
8.
Zurück zum Zitat Ferrell B, Dow KH (1997) Quality of life among long-term cancer survivors. Oncology 11:565–576PubMed Ferrell B, Dow KH (1997) Quality of life among long-term cancer survivors. Oncology 11:565–576PubMed
9.
Zurück zum Zitat Grant M, Economou D (2011) Building a critical mass of health-care providers, administrators, and services for cancer survivors. In: Feuerstein M, Ganz PA (eds) Health services for cancer survivors. Springer, New York, pp 261–274CrossRef Grant M, Economou D (2011) Building a critical mass of health-care providers, administrators, and services for cancer survivors. In: Feuerstein M, Ganz PA (eds) Health services for cancer survivors. Springer, New York, pp 261–274CrossRef
12.
Zurück zum Zitat Institute of Medicine [IOM] (2006) In: Hewitt M, Greenfield S, Stovall E (eds) From cancer patient to cancer survivor: Lost in transition. The National Academies Press, Washington DC, pp 9–186 Institute of Medicine [IOM] (2006) In: Hewitt M, Greenfield S, Stovall E (eds) From cancer patient to cancer survivor: Lost in transition. The National Academies Press, Washington DC, pp 9–186
14.
Zurück zum Zitat Lewis FM (2006a) The effects of cancer survivorship on families and caregivers. More research is needed on long-term survivors. [PDF]. Am J Nurs 106(3 Suppl):20–25CrossRef Lewis FM (2006a) The effects of cancer survivorship on families and caregivers. More research is needed on long-term survivors. [PDF]. Am J Nurs 106(3 Suppl):20–25CrossRef
15.
Zurück zum Zitat Mao JJ, Bowman MA, Stricker CT, DeMichele A, Jacobs L, Chan D, Armstrong K (2009) Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol 27(6):933–938PubMedCrossRef Mao JJ, Bowman MA, Stricker CT, DeMichele A, Jacobs L, Chan D, Armstrong K (2009) Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol 27(6):933–938PubMedCrossRef
16.
Zurück zum Zitat Miller K, Triano L (2008) Medical issues in cancer survivors—a review. The Cancer Journal 14(6):375–387PubMedCrossRef Miller K, Triano L (2008) Medical issues in cancer survivors—a review. The Cancer Journal 14(6):375–387PubMedCrossRef
23.
Zurück zum Zitat Rowland JH, Stefanek M (2008) Introduction: partnering to embrace the future of cancer survivorship research and care. Cancer 112(11 Suppl):2523–2528PubMedCrossRef Rowland JH, Stefanek M (2008) Introduction: partnering to embrace the future of cancer survivorship research and care. Cancer 112(11 Suppl):2523–2528PubMedCrossRef
24.
Zurück zum Zitat Surveillance Epidemiology and End Results Program (2007 released) US estimated complete prevalence counts on 1/1/2004. From National Cancer Institute, DCCPS, Surveillance Research Program, Statistical Research and Applications Branch, based on November 2006 SEER data submission. www.seer.cancer.gov Surveillance Epidemiology and End Results Program (2007 released) US estimated complete prevalence counts on 1/1/2004. From National Cancer Institute, DCCPS, Surveillance Research Program, Statistical Research and Applications Branch, based on November 2006 SEER data submission. www.​seer.​cancer.​gov
26.
Zurück zum Zitat Yancik R, Ganz PA, Varricchio CG, Conley B (2001) Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol 19(4):1147–1151PubMed Yancik R, Ganz PA, Varricchio CG, Conley B (2001) Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol 19(4):1147–1151PubMed
Metadaten
Titel
Educating Health Care Professionals to Provide Institutional Changes in Cancer Survivorship Care
verfasst von
Marcia Grant
Denice Economou
Betty Ferrell
Gwen Uman
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Education / Ausgabe 2/2012
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-012-0314-7

Weitere Artikel der Ausgabe 2/2012

Journal of Cancer Education 2/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.